Valuation : AstraZeneca PLC

Market Cap 252B 379,864B 217B 204B 186B 349B 23,952B 351B 2,412B 938B 12,146B 945B 925B 40,216B P/E 2026 *
20.9x
P/E 2027 * 18.3x
Enterprise Value 271B 409,027B 233B 219B 200B 376B 25,791B 378B 2,597B 1,010B 13,078B 1,018B 996B 43,303B EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.94x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.19%
1 day-0.46%
1 week-2.73%
1 month-2.99%
3 months-5.63%
6 months-14.81%
Current year-7.90%
1 week 64,700
Extreme 64700
67,125
1 month 60,650
Extreme 60650
68,000
Current year 60,650
Extreme 60650
80,275
1 year 50,650
Extreme 50650
80,275
3 years 24,182
Extreme 24182
80,275
5 years 4,889
Extreme 4889
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-2.73% - - 252B
+0.72%-5.33%+58.87%+109.65% 1,031B
+0.96%-2.01%+50.31%+66.78% 641B
+1.11%-2.39%+22.42%+75.06% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+0.64%-2.12%+50.87%+68.62% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+1.40%-0.32%+31.57%+93.47% 181B
Average +0.85%-2.98%+28.67%+50.12% 403.31B
Weighted average by Cap. +0.82%-3.97%+37.76%+66.13%

Financials

2026 *2027 *
Net sales 63.24B 95,426B 54.45B 51.12B 46.67B 87.67B 6,017B 88.3B 606B 236B 3,051B 237B 232B 10,103B 66.82B 100,830B 57.53B 54.02B 49.31B 92.64B 6,358B 93.3B 640B 249B 3,224B 251B 245B 10,675B
Net income 12.02B 18,141B 10.35B 9.72B 8.87B 16.67B 1,144B 16.79B 115B 44.81B 580B 45.14B 44.16B 1,921B 13.61B 20,538B 11.72B 11B 10.04B 18.87B 1,295B 19B 130B 50.73B 657B 51.1B 49.99B 2,174B
Net Debt 19.33B 29,163B 16.64B 15.62B 14.26B 26.79B 1,839B 26.98B 185B 72.03B 932B 72.56B 70.99B 3,087B 11.65B 17,583B 10.03B 9.42B 8.6B 16.15B 1,109B 16.27B 112B 43.43B 562B 43.75B 42.8B 1,862B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
31/08/26 ARS 64,975.00 -0.46% 246
28/08/26 ARS 65,275.00 -1.02% 5,493
27/08/26 ARS 65,950.00 -1.35% 2,552
26/08/26 ARS 66,850.00 -1.40% 976
25/08/26 ARS 67,800.00 +1.50% 942
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.30USD
Average target price
212.68USD
Spread / Average Target
+31.04%

Quarterly revenue - Rate of surprise